Showing results (621-630 of 1,300) with videos related to
Sort By:
Pageof 130
Heart (British Cardiac Society)|August 29, 2014
Stent thrombosis in early-generation drug-eluting stents versus newer-generation everolimus-eluting stent assorted by LVEFNick van Boven, Stephan Windecker, Victor A Umans, et al.JACC. Cardiovascular Interventions|November 15, 2025
Real-Time Fluoroscopic Assessment of Underexpansion Predicts Hemodynamic Valve Deterioration Following TAVR With Balloon-Expandable DeviceDomenico Angellotti, Nadir Elamin, Cyril Ferro, et al.Journal of the American Heart Association|May 31, 2021
Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer-Generation Drug-Eluting StentsRayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, et al.International Journal of Cardiology|October 11, 2017
Incidence and impact of renal dysfunction on clinical outcomes after transcatheter aortic valve implantationAnna Franzone, Stefan Stortecky, Thomas Pilgrim, et al.Journal of the American Heart Association|November 19, 2016
Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic StenosisThomas Pilgrim, Stefan Stortecky, Fabian Nietlispach, et al.American Heart Journal|March 11, 2026
IMPACT OF TOTAL STENT LENGTH ON LONG-TERM OUTCOMES WITH DIFFERENT NEWER-GENERATION DRUG-ELUTING STENT DESIGNS IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: A SUBGROUP ANALYSIS FROM THE BIOSTEMI ES RANDOMIZED TRIALJuan F Iglesias, Marco Roffi, Dik Heg, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 26, 2012
SPIRIT Women, evaluation of the safety and efficacy of the XIENCE V everolimus-eluting stent system in female patients: referral time for coronary intervention and 2-year clinical outcomesMarie-Claude Morice, Ghada W Mikhail, Fina Mauri i Ferré, et al.American Heart Journal|May 16, 2023
Ultrathin-strut vs thin-strut drug-eluting stents for multi and single-stent lesions: A lesion-level subgroup analysis of 2 randomized trialsJonas D Häner, Miklos Rohla, Sylvain Losdat, et al.Journal of the American College of Cardiology|February 4, 2022
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous InterventionRalf E Harskamp, Alexander C Fanaroff, Renato D Lopes, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 25, 2022
Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trialsRayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, et al.Pageof 130